Join Our 20,000+ Subscribers. Get Weekly News Sent To Your Email
Subscribe to our newsletter and stay updated on the latest Critical Care Medicine related news.
See Past Critical Care Newsletter issues

Subscribe to Newsletter

FDA Approves Zinplava to Reduce Recurrence of Clostridium difficile Infection in Adult Patients

mercknewsroom.com October 28, 2016

Clostridium difficile Infection

FDA Approves Merck’s ZINPLAVA (bezlotoxumab) to Reduce Recurrence of Clostridium difficile Infection (CDI) in Adult Patients Receiving Antibacterial Drug Treatment for CDI Who Are at High Risk of CDI Recurrence.

antibacterial CDI drugs FDA infection treatment

Invasive Fungal Infections in Non-neutropenic Patients

Microbial Dynamics and Pulmonary Immune Responses in COVID-19 Secondary Bacterial Pneumonia

Outcomes and inflammation changes in different types of immunocompromised patients with critically ill COVID-19 admitted to ICU

COVID-19 and the Cardiovascular System: From Pathophysiology to Clinical Management

COVID-19 and the Cardiovascular System: From Pathophysiology to Clinical Management

ICU Quick Drug Guide

Severe Sepsis Care in the Emergency Department

Mechanical Ventilation in the ICU: A New Approach and Treatment

The Nurses: A Year of Secrets, Drama, and Miracles with the Heroes of the Hospital

Biomarkers in Trauma, Injury and Critical Care (Biomarkers in Disease: Methods, Discoveries and Applications)

A Nurse’s Story

Oxford Textbook of Critical Care

Hemodynamic Monitoring Using Echocardiography in the Critically Ill

The Washington Manual of Critical Care 4th Edition

Quick Reference to Critical Care

Bedside Procedures in the ICU

Trauma Team Dynamics: A Trauma Crisis Resource Management Manual

EKG/ECG Interpretation Made Easy

Evidence-Based Critical Care: A Case Study Approach

Clinical Examination Skills in the Adult Critically Ill Patient